Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.268,68
-0,33%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lipocine Inc (LPCN) Lipocine Inc (LPCN) Notizie

Lipocine Inc

LPCN
3,63
0,09 (2,54%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/2/202515:00EDGAR2Form 8-K - Current report
06/2/202515:30EDGAR2Form 8-K - Current report
06/2/202514:00PRNUSLipocine Receives Updated Regulatory Guidance on LPCN 1154
03/1/202501:47EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
03/1/202501:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202415:30EDGAR2Form 8-K - Current report
17/12/202414:00PRNUSFDA Grants Fast Track Designation to Lipocine for LPCN 1148..
13/12/202412:06EDGAR2Form 8-K - Current report
18/11/202415:45EDGAR2Form 8-K - Current report
18/11/202414:00PRNUSLipocine Announces Publication and Discussion of LPCN 1148..
07/11/202415:35EDGAR2Form 8-K - Current report
07/11/202414:00PRNUSLipocine Announces Financial Results for the Third Quarter..
07/11/202412:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202422:37EDGAR2Form 8-K - Current report
31/10/202414:35EDGAR2Form 8-K - Current report
31/10/202413:00PRNUSLipocine Announces Distribution and License Agreement with..
16/10/202422:05EDGAR2Form 8-K - Current report
10/10/202414:00PRNUSLipocine Announces Positive Oral Brexanolone Quantitative..
10/10/202412:04EDGAR2Form 8-K - Current report
08/10/202415:30EDGAR2Form 8-K - Current report
08/10/202414:00PRNUSLipocine Announces Supply and Distribution Agreement with..
02/10/202415:35EDGAR2Form 8-K - Current report
02/10/202414:00PRNUSLipocine to Host Virtual KOL Event on LPCN 2401 for Improved..
30/9/202415:35EDGAR2Form 8-K - Current report
30/9/202414:00PRNUSLipocine to Present at H.C. Wainwright 8th Annual MASH..
05/9/202415:35EDGAR2Form 8-K - Current report
05/9/202414:00PRNUSLipocine Announces Phase 2 Data on LPCN 2401 to be Presented..
27/8/202417:23EDGAR2Form 8-K - Current report
27/8/202414:00PRNUSLipocine to Present at H.C. Wainwright 26th Annual Global..
08/8/202414:00PRNUSLipocine Announces Financial Results for the Second Quarter..
08/8/202412:20EDGAR2Form 8-K - Current report
08/8/202412:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:05EDGAR2Form 8-K/A - Current report: [Amend]
25/6/202414:00PRNUSLipocine Announces LPCN 1154 Meets Bioequivalence with IV..
10/6/202415:00EDGAR2Form 8-K - Current report
10/6/202414:00PRNUSLipocine Presents 52 Week Results from LPCN 1148 Phase 2..
07/6/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202422:32EDGAR2Form 8-K - Current report
03/6/202423:15EDGAR2Form 8-K - Current report
03/6/202423:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202414:00PRNUSLipocine Announces Financial Results for the First Quarter..
09/5/202412:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202412:03EDGAR2Form 8-K - Current report
08/5/202414:00PRNUSLipocine Announces Late Breaking Oral Presentation of Data..
Apertura: 3,52 Min: 3,474 Max: 3,7866
Chiusura: 3,54

La tua Cronologia

NASDAQ
LPCN
Lipocine
BIT
UC00B6
Unicredit Bank
NASDAQ
WHFCL
WhiteHorse Finance
AQSE
IES
Invinity Energy Systems
BIT
F19799
Vontobel Financial Produ...
LSE
KWS
Keywords Studios
NASDAQ
FBZVX
Algonquin Fixed Income 2...
TSX
228A
Opro
AQSE
MSYS.GB
Microsaic Systems
BIT
1GD
General Dynamics
BIT
UB7RY4
Unicredit Bank
BIT
UI119C
Unicredit Bank
BIT
EGLA
Euro Group Laminations
DOWI
DJCIKCT
DJ Commodity Index Coffe...
BIT
F39058
Vontobel Financial Produ...
BOV
NEMO5
SUZANO HOLD PNA
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci